160 related articles for article (PubMed ID: 8743006)
1. A foveal-sparing pattern of cytomegalovirus retinitis in the acquired immunodeficiency syndrome.
Luckie AP; Ai E
Aust N Z J Ophthalmol; 1996 Feb; 24(1):53-9. PubMed ID: 8743006
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
4. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis.
Marx JL; Kapusta MA; Patel SS; LaBree LD; Walonker F; Rao NA; Chong LP
Arch Ophthalmol; 1996 Jul; 114(7):815-20. PubMed ID: 8660164
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus papillitis in patients with acquired immune deficiency syndrome. Visual prognosis of patients treated with ganciclovir and/or foscarnet.
Patel SS; Rutzen AR; Marx JL; Thach AB; Chong LP; Rao NA
Ophthalmology; 1996 Sep; 103(9):1476-82. PubMed ID: 8841309
[TBL] [Abstract][Full Text] [Related]
6. The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
Ciulla TA; Rutledge BK; Morley MG; Duker JS
Ophthalmic Surg Lasers; 1998 Mar; 29(3):198-206. PubMed ID: 9547773
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bilateral cytomegalovirus retinitis with sustained-release ganciclovir implants in a child.
Malley DS; Barone R; Heinemann MH
Am J Ophthalmol; 1996 Nov; 122(5):731-2. PubMed ID: 8909217
[TBL] [Abstract][Full Text] [Related]
8. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
9. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
Dodds EM; Lowder CY; Foster RE; Avery RK; Prayson RA
Arch Ophthalmol; 1996 Jul; 114(7):896-7. PubMed ID: 8660181
[No Abstract] [Full Text] [Related]
10. COMPARISON OF VISUAL PROGNOSIS AND CLINICAL FEATURES OF CYTOMEGALOVIRUS RETINITIS IN HIV AND NON-HIV PATIENTS.
Kim DY; Jo J; Joe SG; Kim JG; Yoon YH; Lee JY
Retina; 2017 Feb; 37(2):376-381. PubMed ID: 28118285
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
Flores-Aguilar M; Kuppermann BD; Quiceno JI; Dankner WM; Wolf DG; Capparelli EV; Connor JD; Sherwood CH; Fullerton S; Gambertoglio JG
Ophthalmology; 1993 Jul; 100(7):1022-31. PubMed ID: 8391674
[TBL] [Abstract][Full Text] [Related]
12. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus optic neuritis: characteristics, therapy and survival.
Mansor AM; Li HK
Ophthalmologica; 1995; 209(5):260-6. PubMed ID: 8570149
[TBL] [Abstract][Full Text] [Related]
14. Cystoid macular edema associated with cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Silverstein BE; Smith JH; Sykes SO; Jones MR; Schwartz D; Cunningham ET
Am J Ophthalmol; 1998 Mar; 125(3):411-5. PubMed ID: 9512171
[TBL] [Abstract][Full Text] [Related]
15. Treatment of recurrent cytomegalovirus retinitis with the ganciclovir implant.
Roth DB; Feuer WJ; Blenke AJ; Davis JL
Am J Ophthalmol; 1999 Mar; 127(3):276-82. PubMed ID: 10088736
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of CMV retinitis with intravitreal foscarnet].
Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
[TBL] [Abstract][Full Text] [Related]
17. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group.
Holbrook JT; Davis MD; Hubbard LD; Martin BK; Holland GN; Jabs DA; Gilpin AK; Meinert C; Reshef DS
Arch Ophthalmol; 2000 Sep; 118(9):1196-204. PubMed ID: 10980764
[TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant.
Hatton MP; Duker JS; Reichel E; Morley MG; Puliafito CA
Retina; 1998; 18(1):50-5. PubMed ID: 9502281
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
Ries E; Mühlbauer B; Ruhswurm I; Krepler K; Derbolav A; Svolba G; Rieger A; Wedrich A
Ophthalmologica; 1998; 212(4):239-43. PubMed ID: 9672212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
